Site-Ready Referrals: How to Keep Device Trial Patients Moving After Handoff

A patient completes the screener, confirms the study criteria by phone and agrees to be referred. The referral reaches the clinical site. Then follow-up gets delayed while the site coordinator manages scheduled visits. By the time the clinical site calls, the patient may no longer respond.

Every step before the handoff can work and the clinical trial can still lose the patient. Even qualified referrals can stall before site screening, and every stalled referral puts enrollment targets at risk. Planning the handoff matters as much as attracting and pre-screening the right patients.

The referrals nobody called

Paul Egli, Senior Vice President of Sales and Business Development at 83bar, learned this before 83bar existed. His team ran a site network of about 35 physicians and sent high-intent patients to the practices by email.

“We were emailing those into the practice without thinking about what is everyday life in a practice like,” Paul says. “It is controlled chaos.”
Four weeks after launch, the physicians asked where the patients were. Paul recalls the answer: “We’ve been emailing them to you the last month, but nobody’s called them.”

The fix, in Paul’s words: “We learned really quickly we need to have a stutter step in there.” Today, he says, “we’re just dialing the provider and letting the patient then have that discussion, making sure that they get scheduled.”

Patient interest needs timely follow-up

In feasibility tests run by Antidote, an 83bar company, respondents who met initial survey criteria reported strong interest in hearing from a clinical site. That stated interest doesn’t guarantee a patient will progress through site screening, but it shows what’s at stake when follow-up is slow.

Feasibility test What respondents who met initial criteria reported
Parkinson’s disease study 100% wanted to be contacted if the study enrolled locally, and 91.4% were willing to attend clinic visits
Heart failure with preserved ejection fraction (HFpEF) study 100% wanted to be contacted if the study recruited locally

Strong initial interest doesn’t guarantee a patient stays engaged after referral. Delayed follow-up from the clinical site is one potential barrier, which makes timely communication an important part of the handoff.

A lead list versus a site-ready referral

A lead list gives the clinical site A site-ready referral gives the clinical site
A name, an email and a phone number Contact details plus the patient’s consent and preferred time to be contacted
Screener answers, unchecked Which criteria the patient confirmed, and how (screener, phone call or records)
No context on what’s still open The questions still left for site screening, such as test values or imaging
A patient who doesn’t know what happens next A patient who knows who will call, when, and what to bring
No record after the email is sent A tracked referral with a confirmed receipt and a next step

How to keep referrals moving after handoff

  • Agree on follow-up time with each clinical site before launch. Set how quickly a site coordinator will contact a new referral, and how the clinical site confirms receipt.
  • Connect the patient and the clinical site on the same call where possible. A scheduled appointment holds better than a referral waiting for a callback.
  • Tell the patient what happens next. The patient should know who will call, roughly when, and which records to gather.
  • Track every referral at each stage. Follow each referral through contact, scheduling, site screening and, where applicable, enrollment or randomization. Record why patients discontinue or fail site screening, and agree on who updates referral status after handoff.
  • Send screen-fail reasons back to pre-screening. If clinical sites keep failing patients on the same criterion, that criterion belongs earlier in the screener or the phone confirmation.

What a working handoff looks like

In one cardiovascular device program, 83bar referred 15,000 patients. More than 90% of randomizations came from those referrals, site satisfaction reached 80% and enrollment finished on time. These results reflect the full program, not the handoff alone, but they show what coordinated referrals and downstream tracking can support across a clinical trial.

Frequently asked questions

  • What is a site-ready referral? A referral the clinical site can act on right away: confirmed criteria, consent to be contacted, open questions for site screening and a patient who knows what happens next.
  • Why do qualified patients drop out after referral? Patients can disengage for several reasons, including scheduling conflicts, travel requirements, changes in eligibility or delayed communication. Busy clinical sites prioritize scheduled patients, so referrals sent only by email can wait. Timely follow-up from the clinical site helps keep interested patients engaged.
  • How should sponsors track referrals after handoff? Track each referral through contact, scheduling and site screening, with a reason for every patient lost, so the study team can see where referrals stall and at which clinical sites.

Find out where your referrals stall

83bar helps medtech sponsors coordinate the handoff between pre-screened patients and clinical sites, and see exactly where referrals stall. The 83bar clinical contact center connects each patient with the clinical site, and each referral is tracked through contact, scheduling and site screening, so the study team can spot which stages and clinical sites are losing patients